Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hematology
Reference31 articles.
1. New anticoagulants
2. Rivaroxaban, an oral direct factor Xa inhibitor
3. Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict
4. New Anticoagulants for Treatment of Venous Thromboembolism
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dual-target inhibitor screening against thrombin and factor Xa simultaneously by mass spectrometry;Analytica Chimica Acta;2017-10
2. A novel approach indirectly comparing benefit–risk balance across anti-thrombotic therapies in patients with atrial fibrillation;European Heart Journal - Cardiovascular Pharmacotherapy;2015-01
3. Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients;Heart;2013-09-05
4. Novel Oral Anticoagulants in Atrial Fibrillation: A Meta-analysis of Large, Randomized, Controlled Trials vs Warfarin;Clinical Cardiology;2013-01-21
5. Treating seizures and epilepsy with anticoagulants?;Frontiers in Cellular Neuroscience;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3